KMID : 0606920140220030200
|
|
Biomolecules & Therapeutics 2014 Volume.22 No. 3 p.200 ~ p.206
|
|
N-(p-Coumaryol)-Tryptamine Suppresses the Activation of JNK/c-Jun Signaling Pathway in LPS-Challenged RAW264.7 Cells
|
|
Vo Van Anh
Lee Jae-Won Park Jun-Ho Kwon Jae-Hyun Lee Hee-Jae Kim Sung-Soo Kwon Yong-Soo Chun Wan-Joo
|
|
Abstract
|
|
|
N-(p-Coumaryol) tryptamine (CT), a phenolic amide, has been reported to exhibit anti-oxidant and anti-inflammatory activities. However, the underlying mechanism by which CT exerts its pharmacological properties has not been clearly demonstrated. The objective of this study is to elucidate the anti-inflammatory mechanism of CT in lipopolysaccharide (LPS)-challenged RAW264.7 macrophage cells. CT significantly inhibited LPS-induced extracellular secretion of pro-inflammatory mediators such as nitric oxide (NO) and PGE2, and protein expressions of iNOS and COX-2. In addition, CT significantly suppressed LPS-induced secretion of pro-inflammatory cytokines such as TNF-¥á and IL-1¥â. To elucidate the underlying anti-inflammatory mechanism of CT, involvement of MAPK and Akt signaling pathways was examined. CT significantly attenuated LPS-induced activation of JNK/c-Jun, but not ERK and p38, in a concentration-dependent manner. Interestingly, CT appeared to suppress LPS-induced Akt phosphorylation. However, JNK inhibition, but not Akt inhibition, resulted in the suppression of LPS-induced responses, suggesting that JNK/c-Jun signaling pathway significantly contributes to LPS-induced inflammatory responses and that LPS-induced Akt phosphorylation might be a compensatory response to a stress condition. Taken together, the present study clearly demonstrates CT exerts anti-inflammatory activity through the suppression of JNK/c-Jun signaling pathway in LPS-challenged RAW264.7 macrophage cells.
|
|
KEYWORD
|
|
N-(p-Coumaroyl) tryptamine, RAW 264.7 cells, Lipopolysaccharide, iNOS, COX-2, JNK, c-Jun
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|